Loukovaara, Sirpa <br/><br/>
Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.  [electronic resource] 

 -  Acta ophthalmologica  Sep 2013 
 - 531-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-3768 
<br/><br/><label>Standard No.: </label>10.1111/j.1755-3768.2012.02473.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiopoietin-1--metabolism<br/>Diabetes Mellitus, Type 1--complications<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Retinopathy--metabolism<br/>Enzyme-Linked Immunosorbent Assay<br/>Erythropoietin--metabolism<br/>Female<br/>Humans<br/>Male<br/>Matrix Metalloproteinase 2--metabolism<br/>Matrix Metalloproteinase 9--metabolism<br/>Middle Aged<br/>Prospective Studies<br/>Retinal Neovascularization--metabolism<br/>Retinal Perforations--metabolism<br/>Tomography, Optical Coherence<br/>Transforming Growth Factor beta1--metabolism<br/>Up-Regulation<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Vesicular Transport Proteins--metabolism<br/>Vitrectomy<br/>Vitreous Body--metabolism